| Subscribe To Our Free Newsletter |
Granules India Andhra Pradesh facility gets EIR from USFDA
Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma City (JNPC), Anakapalli, Andhra Pradesh.
